Investigating the Targets of MIR-15a and MIR-16-1 in Patients with Chronic Lymphocytic Leukemia (CLL)

被引:53
作者
Hanlon, Katy
Rudin, Claudius E.
Harries, Lorna W.
机构
[1] Department of Haematology, Royal Devon and Exeter NHS Foundation Trust, Exeter, Devon
[2] Department of Molecular Genetics, Royal Devon and Exeter NHS Foundation Trust, Exeter, Devon
[3] Institute of Biomedical and Clinical Sciences, Peninsula Medical School, Exeter, Devon
来源
PLOS ONE | 2009年 / 4卷 / 09期
关键词
TUMOR-SUPPRESSOR; CHROMOSOME; 13Q14; MICRORNAS; GENES; CLONING; REGION; RAS; EXPRESSION; SEQUENCE; DELETION;
D O I
10.1371/journal.pone.0007169
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: MicroRNAs (miRNAs) are short, noncoding RNAs that regulate the expression of multiple target genes. Deregulation of miRNAs is common in human tumorigenesis. The miRNAs, MIR-15a/16-1, at chromosome band 13q14 are down-regulated in the majority of patients with chronic lymphocytic leukaemia (CLL). Methodology/Principal Findings: We have measured the expression of MIR-15a/16-1, and 92 computationally-predicted MIR-15a/16-1 target genes in CLL patients and in normal controls. We identified 35 genes that are deregulated in CLL patients, 5 of which appear to be specific targets of the MIR-15a/16-1 cluster. These targets included 2 genes (BAZ2A and RNF41) that were significantly up-regulated (p < 0.05) and 3 genes (RASSF5, MKK3 and LRIG1) that were significantly downregulated (p < 0.05) in CLL patients with down-regulated MIR-15a/16-1 expression. Significance: The genes identified here as being subject to MIR-15a/16-1 regulation could represent direct or indirect targets of these miRNAs. Many of these are good biological candidates for involvement in tumorigenesis and as such, may be important in the aetiology of CLL.
引用
收藏
页数:7
相关论文
共 46 条
[1]   FLRF, a novel evolutionarily conserved RING finger gene, is differentially expressed in mouse fetal and adult hematopoietic stem cells and progenitors [J].
Abdullah, JM ;
Li, XY ;
Nachtman, RG ;
Jurecic, R .
BLOOD CELLS MOLECULES AND DISEASES, 2001, 27 (01) :320-333
[2]   Norel inhibits tumor cell growth independent of Ras or the MST1/2 kinases [J].
Aoyama, Y ;
Avruch, J ;
Zhang, XF .
ONCOGENE, 2004, 23 (19) :3426-3433
[3]  
*APPL BIOS, 1997, US B APPL BIOS, V2, P11
[4]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[5]   Prediction and validation of microRNAs and their targets [J].
Bentwich, I .
FEBS LETTERS, 2005, 579 (26) :5904-5910
[6]  
Bullrich F, 2001, CANCER RES, V61, P6640
[7]   Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia [J].
Calin, GA ;
Dumitru, CD ;
Shimizu, M ;
Bichi, R ;
Zupo, S ;
Noch, E ;
Aldler, H ;
Rattan, S ;
Keating, M ;
Rai, K ;
Rassenti, L ;
Kipps, T ;
Negrini, M ;
Bullrich, F ;
Croce, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (24) :15524-15529
[8]   Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers [J].
Calin, GA ;
Sevignani, C ;
Dan Dumitru, C ;
Hyslop, T ;
Noch, E ;
Yendamuri, S ;
Shimizu, M ;
Rattan, S ;
Bullrich, F ;
Negrini, M ;
Croce, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (09) :2999-3004
[9]   MiR-15a and miR-16-1 cluster functions in human leukemia [J].
Calin, George A. ;
Cimmino, Amelia ;
Fabbri, Muller ;
Ferracin, Manuela ;
Wojcik, Sylwia E. ;
Shimizu, Masayoshi ;
Taccioli, Cristian ;
Zanesi, Nicola ;
Garzon, Ramiro ;
Aqeilan, Rami I. ;
Alder, Hansjuerg ;
Volinia, Stefano ;
Rassenti, Laura ;
Liu, Xiuping ;
Liu, Chang-gong ;
Kipps, Thomas J. ;
Negrini, Massimo ;
Croce, Carlo M. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (13) :5166-5171
[10]   INVESTIGATION OF MICRORNA ALTERATIONS IN LEUKEMIAS AND LYMPHOMAS [J].
Calin, George Adrian ;
Croce, Carlo Maria .
MICRORNA METHODS, 2007, 427 :193-213